Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse

Bone Marrow Transplantation volume 37, pages 493–498 (2006)Cite this article

Abstract

The C-reactive protein (CRP) is an acute-phase protein produced by hepatocytes, and is a reliable marker of systemic inflammation, which is relevant to the release of the proinflammatory cytokines. The value of monitoring the CRP levels after stem cell transplantation (SCT) can identify patients at risk of treatment-related complications and mortality. Inflammatory cytokines facilitate donor T-cell activation via antigen presenting cells immediately after SCT. This study examined the relationship between the post-SCT CRP levels and a leukemic relapse. Fifty-four consecutively transplanted patients who relapsed after the allogeneic SCT were compared with nonrelapsing patients. The serum CRP levels were measured on day 0 and every 7 days thereafter until 4 weeks after the SCT. The mean CRP levels throughout the early post-SCT episode were significantly lower in the relapsing patients than in those who did not experience relapse (mean±s.e.: 26.8±6.3 vs 65.3±9.4 for first week, P=0.001; 23.9±3.8 vs 44.6±6.6 for second week, P=0.008). Univariate analysis showed that the CRP level on the first and second week, and graft-versus-host disease were significantly associated with a relapse. Multivariate analysis showed that the CRP level on the first week was the strongest independent variable predicting the risk of a relapse after SCT (P=0.04). These results indicate that the serum CRP levels early after allogeneic SCT might display the graft-versus-leukemia (GvL) effect. CRP is a surrogate of the proinflammatory cytokine release that was not measured in this study. The GvL effect appears to be efficiently strengthened by the high CRP levels that may be reflecting T-cell activation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Barrett AJ . Mechanisms of the graft-versus-leukemia reaction. Stem Cells 1997; 15: 248–258.

    Article  CAS  PubMed  Google Scholar 

  2. Uberti JP, Ayash L, Braun T, Reynolds C, Silver S, Ratanatharathorn V . Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes. Bone Marrow Transplant 2004; 34: 425–431.

    Article  CAS  PubMed  Google Scholar 

  3. Kumar L . Leukemia: management of relapse after allogeneic bone marrow transplantation. J Clin Oncol 1994; 12: 1710–1717.

    Article  CAS  PubMed  Google Scholar 

  4. Schultz DR, Arnold PI . Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein and fibrinogen. Sem Arthritis Rheum 1990; 20: 129–147.

    Article  CAS  Google Scholar 

  5. Cooke KR, Okliewicz K, Erickson N, Ferrara JL . The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J Endotoxin Res 2002; 8: 441–448.

    Article  CAS  PubMed  Google Scholar 

  6. Schots R, Van Riet I, Ben Othman T, Trullemans F, De Waele M, Van Camp B et al. An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation. Bone Marrow Transplant 2002; 30: 441–446.

    Article  CAS  PubMed  Google Scholar 

  7. Schots R, Kaufman L, Van Riet I, Ben Othman T, De Waele M, Van Camp B et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 2003; 17: 1150–1156.

    Article  CAS  PubMed  Google Scholar 

  8. Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P et al. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 347–354.

    Article  CAS  PubMed  Google Scholar 

  9. Van Rhee F, Lin F, Cullis O, Spencer A, Cross NC, Chase A et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 1994; 83: 3377–3383.

    CAS  PubMed  Google Scholar 

  10. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  PubMed  Google Scholar 

  11. Weisdorf DJ, Snover DC, Haake R, Miller WJ, McGlave PB, Blazar B et al. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood 1990; 76: 624–629.

    CAS  PubMed  Google Scholar 

  12. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  13. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–207.

    CAS  PubMed  Google Scholar 

  14. Atkinson K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM . Consensus among bone marrow transplanters for diagnosis, grading, and treatment of chronic graft-versus-host disease. Bone Marrow Transplant 1989; 4: 247–254.

    CAS  PubMed  Google Scholar 

  15. Mehta J, Powles R, Kulkarni S, Treleaven J, Singhal S . Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adults patients. Bone Marrow Transplant 1997; 20: 129–135.

    Article  CAS  PubMed  Google Scholar 

  16. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED . Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116–122.

    Article  CAS  PubMed  Google Scholar 

  17. Choi SM, Lee DG, Choi JH, Yoo JH, Kim YJ, Park SH et al. Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea. Int J Hematol 2005; 81: 69–74.

    Article  PubMed  Google Scholar 

  18. Riddell SR, Berger C, Murata M, Randolph S, Warren EH . The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation. Blood Rev 2003; 17: 153–162.

    Article  PubMed  Google Scholar 

  19. Xun CQ, Thompson JS, Jennings CD, Brown SA, Widmer MB . Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 1994; 83: 2360–2367.

    CAS  PubMed  Google Scholar 

  20. Cavender DE, Haskard DO, Joseph B, Ziff M . Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol 1986; 136: 203–207.

    CAS  PubMed  Google Scholar 

  21. Leeuwenberg JF, Van Damme J, Meager T, Jeunhomme TM, Buurman WA . Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells. Eur J Immunol 1988; 18: 1469–1472.

    Article  CAS  PubMed  Google Scholar 

  22. Pober JS, Collins T, Gimbrone Jr MA, Libby P, Reiss CS . Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation 1986; 41: 141–146.

    Article  CAS  PubMed  Google Scholar 

  23. Thornhill MH, Wellicome SM, Mahiouz DL, Lanchbury JS, Kyan-Aung U, Haskard DO . Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J Immunol 1991; 146: 592–598.

    CAS  PubMed  Google Scholar 

  24. Matzinger P . The danger model: a renewed sense of self. Science 2002; 296: 301–305.

    Article  CAS  PubMed  Google Scholar 

  25. Steinman RM, Nussenzweig MC . Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002; 99: 351–358.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Banchereau J, Steinman RM . Dendritic cells and the control of immunity. Nature 1998; 392: 245–252.

    Article  CAS  PubMed  Google Scholar 

  27. Wang J, Shaw JL, Mullen CA . Down-regulation of antihost alloreactivity after bone marrow transplant permits relapse of hematological malignancy. Cancer Res 2002; 62: 208–212.

    CAS  PubMed  Google Scholar 

  28. Arber C, Passweg JR, Fluckiger U, Pless M, Gregor M, Tichelli A et al. C-reactive protein and fever in neutropenic patients. Scand J Infect Dis 2000; 32: 515–520.

    Article  CAS  PubMed  Google Scholar 

  29. Nash RA, Storb R . Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL. Curr Opin Immunol 1996; 8: 674–680.

    Article  CAS  PubMed  Google Scholar 

  30. Szalai AJ, McCrory MA, Cooper GS, Wu J, Kimberly RP . Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes Immun 2002; 3: 14–19.

    Article  CAS  PubMed  Google Scholar 

  31. Zee RY, Ridker PM . Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002; 162: 217–219.

    Article  CAS  PubMed  Google Scholar 

  32. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun 2001; 2: 61–70.

    Article  CAS  PubMed  Google Scholar 

  33. Min CK, Lee WY, Min DJ, Lee DG, Kim YJ, Park YH et al. The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 935–940.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Catholic Hemopoietic Stem Cell Transplantation Center, The Catholic University of Korea, Seoul, Korea

    C-K Min, S Y Kim, K S Eom, Y J Kim, H J Kim, S Lee, D W Kim, J W Lee, W S Min & C C Kim

Authors
  1. C-K Min
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Y Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K S Eom
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y J Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H J Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D W Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J W Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W S Min
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C C Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C-K Min.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Min, CK., Kim, S., Eom, K. et al. Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse. Bone Marrow Transplant 37, 493–498 (2006). https://doi.org/10.1038/sj.bmt.1705276

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705276

Keywords

This article is cited by

Search

Advanced search

Quick links